COMMUNIQUÉS West-GlobeNewswire

Iovance Biotherapeutics to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Tuesday, November 6, 2018

30/10/2018 - 13:01

SAN CARLOS, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Immune Design to Report Third Quarter 2018 Financial Results and Provide Corporate Update

30/10/2018 - 13:00

SEATTLE and SOUTH SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report third [...]

InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6

30/10/2018 - 13:00

Conference Call Scheduled for 8am Eastern Time TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of [...]

Daré Announces Two Late-Breaking Abstracts to be Presented at the American Association of Pharmaceutical Scientists (AAPS) in Washington D.C.

30/10/2018 - 13:00

SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it will be presenting two late-breaking abstracts at the [...]

electroCore, Inc. Announces Appointment of Ardelle Ferris as Vice President of Managed Care

30/10/2018 - 13:00

BASKING RIDGE, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Ardelle Ferris to a new [...]

Navicent Health Adopts iCAD’s Breast Cancer Detection and Therapy Solutions to Enhance Patient Care

30/10/2018 - 13:00

Prominent medical center is first in the United States to expand breast health offerings with iCAD’s PowerLook Tomo Detection solution and Xoft System NASHUA, N.H., and MACON, Ga., Oct. 30, 2018 (GLOBE NEWSWIRE) -- iCAD [...]

Shore Group Invests $6M in Healthcare AI Data Startup H1

30/10/2018 - 13:00

H1 is first to arm biopharma companies with live data insights to help fight diseases NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- H1 , the first company to arm healthcare organizations with live data insights to help [...]

ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study

30/10/2018 - 13:00

EDISON, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope

30/10/2018 - 13:00

First-of-its-kind Phase 1 clinical trial using intraventricular delivery of CAR T cells to brains of patients with HER2-positive breast cancer with brain metastases now enrolling patients First patient dosed in Phase 1 [...]

Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer

30/10/2018 - 13:00

Program Developed in Lab of Renowned Cannabis Researcher Dr. Nephi Stella- Lead Candidate for Glioblastoma to Begin Clinical Testing in 2019 VANCOUVER, B.C. and SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Pascal [...]

CymaBay Announces the Initiation of the Seladelpar Global Phase 3 Registration Study (ENHANCE) for the Treatment of Primary Biliary Cholangitis and Additional Corporate Updates

30/10/2018 - 13:00

Phase 3 patient enrollment commenced with multiple investigational sites in the U.S. initiated Team expanded with key hires focused on delivering a high-quality registration package NEWARK, Calif., Oct. 30, 2018 (GLOBE [...]

Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

30/10/2018 - 13:00

CAMBRIDGE, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma ™, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]

Tabula Rasa HealthCare’s CareKinesis Division Successfully Launched Medication Risk Management and Pharmacy Services for Rocky Mountain PACE

30/10/2018 - 12:41

MOORESTOWN, N.J. and COLORADO SPRINGS, Colo., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, President and Chief [...]

Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update

30/10/2018 - 12:30

—Quarter Highlighted by U.S. FDA Approval of ARIKAYCE ® (amikacin liposome inhalation suspension), Followed by Immediate Launch— BRIDGEWATER, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a [...]

Spark Therapeutics to Host Conference Call on Tuesday, Nov. 6 at 8:30 a.m. ET to Discuss Third Quarter Results and Recent Business Highlights

30/10/2018 - 12:30

PHILADELPHIA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, will host a [...]

Trogarzo® Phase III Data Analysis Presented at HIV Drug Therapy Glasgow 2018: Patients not achieving primary endpoint at day 7 experienced clinical benefit by end of study

30/10/2018 - 12:30

MONTREAL, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that data from the phase III clinical trial of Trogarzo ® (ibalizumab-uiyk) injection show that patients [...]

Analyse des données de la phase III de Trogarzo(MD) présentée à HIV Drug Therapy Glasgow 2018: les patients n’ayant pas atteint le principal critère d’évaluation au jour 7 ont obtenu des bénéfices cliniques en cours d’étude

30/10/2018 - 12:30

MONTRÉAL, 30 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui que des données issues de l’étude clinique de phase III de Trogarzo MD (ibalizumab-uiyk) injection [...]

EyePoint Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results Release Date and Conference Call Information

30/10/2018 - 12:30

WATERTOWN, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]

Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic"

30/10/2018 - 12:30

SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple presentations related [...]